QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 0.11588
-- x --
-- x --
-- - --
$ 0.02 - $ 0.29
2
na
na
$ 1.19
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 world-class-leaders-in-psychedelics-form-benzingas-psychedelic-advisory-councilget-to-know-them

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investor...

 psyched-elon-musk-tweets-about-psychedelics-numinus-acquires-novamind-colorado-gov-signs-mdma-legalization-bill

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelic...

 largest-phase-1-dmt-study-in-the-netherlands-a-collaboration-between-entheon--cybin

Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has enter...

 ehave-partners-with-halugen-life-sciences-to-create-a-ketamine-precision-medicine-platform-for-clinical-research

Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to th...

 benzingas-unprecedented-psychedelics-investing-conference-lands-in-miami-on-april-19th

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking...

 psyched-psychedelics-etf-launches-on-nyse-psilocybin-trial-approved-for-depression-dmt-study-begins

The Week in Psychedelics

 psychedelics-biotech-startup-launches-phase-1-study-on-ayahuascas-active-ingredient

Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics com...

 psyched-the-50-publicly-listed-psychedelics-companies-atais-new-subsidiary-pharmather-gets-new-orphan-drug-designation

The Week In Psychedelics

 there-are-now-50-psychedelics-companies-listed-in-the-us---here-they-are

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking in...

 what-do-you-really-know-about-psychedelics-and-psychedelics-stocks

According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.

 psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

 psyched-field-trip-uplists-to-nasdaq-mindmed-to-study-dmt-atai-launches-new-subsidiary-aocs-psychedelics-amendment-rejected

Last week in Psychedelics:

Core News & Articles

89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innov...

 entheon-biomedical-corp-strengthens-its-psychedelic-assisted-protocols-through-acquisition-of-lobo-genetics

Psychedelics biotech company Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:1XU1) has acquired Lobo Genetics Inc., a ...

 psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

 psyched-atai-life-sciences-hits-nasdaq-canada-to-fund-ketamine-trials-mydecine-launches-ai-drug-discovery-platform

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.

 what-do-you-really-know-about-psychedelics-and-psychedelics-stocks

According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.

 video-the-psychedelics-market-with-entheon-biomedical-magicmed-natan-ponieman

Benzinga’s Cannabis Hour is a live show for cannabis investors.

 highlights-from-day-2-of-benzingas-biotech-small-cap-conference

It's curtains down on the virtual, two-day Benzinga Biotech Small Cap Conference, where C-suite executives of top small-cap...